| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Tevogen Bio Holdings Inc. ("Tevogen" or the "Company") (NASDAQ:TVGN), today issued the following statement from Ryan Saadi, M.D., M.P.H., Founder and CEO.
"Tevogen is an asset-rich enterprise, and we plan on sharing a comprehensive inventory of Tevogen's wholly owned internally developed assets and their standard methodology valuation. These intangible assets are not reflected in financial reports due to US GAAP accounting rules, but they do underscore the magnitude of what we have built in such a short time.
It is important for shareholders to understand that these assets, including our intellectual property portfolio, drug development platforms, and proprietary artificial intelligence technology, are fully protected and wholly owned by Tevogen.
With 74% insider ownership and the commitment of our lead investor, we remain focused on advancing our mission, and we will continue to make strategic decisions in the best interests of our long-term shareholders."
Posted In: TVGN
